Drug Ratings gives doctors unprecedented ability to research, choose, and discuss prescription drugs
SERMO Unveils First Global Physician-to-Physician Drug Ratings Tool (Graphic: Business Wire)
NEW YORK--(BUSINESS WIRE)--SERMO, the largest global social network for physicians with 650,000 members worldwide, today announced the groundbreaking new “Drug Ratings” tool. Drug Ratings is the first and only global peer-to-peer prescription drug review system sourced exclusively from verified licensed physicians. With more than a quarter million ratings and 20,000 comments from doctors worldwide to date in the beta release, the Ratings platform is quickly becoming the largest global database of physician feedback on drugs.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170510005048/en/